JP Morgan Chase’s Ardent Health ARDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.41M Buy
242,329
+73,721
+44% +$699K ﹤0.01% 4060
2026
Q1
$1.39M Sell
168,608
-70,109
-29% -$629K ﹤0.01% 4371
2025
Q4
$2.11M Sell
238,717
-44,344
-16% -$513K ﹤0.01% 4021
2025
Q3
$3.75M Sell
283,061
-59,738
-17% -$747K ﹤0.01% 3609
2025
Q2
$4.68M Buy
342,799
+166,483
+94% +$2.24M ﹤0.01% 3240
2025
Q1
$2.42M Buy
176,316
+162,324
+1,160% +$2.37M ﹤0.01% 3732
2024
Q4
$239K Buy
13,992
+5,602
+67% +$97.1K ﹤0.01% 5400
2024
Q3
$154K Buy
+8,390
New +$148K ﹤0.01% 5521

Other funds holding ARDT

JP Morgan Chase's ARDT Position: Q2 2026 in Review

JP Morgan Chase increased its Ardent Health (ARDT) stake by 44% in Q2 2026, buying an estimated $699K and bringing the position to 242,329 shares worth $2.41M. The position accounts for ﹤0.01% of the portfolio, ranked #4060.

JP Morgan Chase first reported a position in ARDT in Q3 2024 and has held it in 8 quarters since. The position peaked at $4.68M in Q2 2025. 139 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

  • JP Morgan Chase held 242,329 shares of Ardent Health worth $2.41M as of Q2 2026.
  • JP Morgan Chase bought 73,721 Ardent Health shares in Q2 2026, an estimated $699K.
  • Ardent Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4060 holding.
  • JP Morgan Chase first reported a position in Ardent Health in Q3 2024 and has held it in 8 quarters since.
  • JP Morgan Chase's Ardent Health position peaked at $4.68M in Q2 2025.
  • 139 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.